American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma

Sergio Giralt, Laurent Garderet, Brian G.M. Durie, +60

Biology of Blood and Marrow Transplantation

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)

Bo Björkstrand, H. Svensson, H. Goldschmidt, +18

Bone Marrow Transplantation

Hematological MalignancyTransplantationMarrow TransplantationOncologyStem Cell Transplantation +7

Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation

M. Hensel, Gerlinde Egerer, H. Goldschmidt, +1

Annals of Oncology

Palliative CareFamily MedicineQuality Of LifeLife AssessmentIndependent Living +8

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation

Anne Catherine Sprynski, Dirk Hose, Alboukadel Kassambara, +5

Leukemia

Growth HormoneDiabetesImmunologyMedicineCell Biology +3

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial

Maximilian Merz, Hans Salwender, Mathias Haenel, +19

Haematologica

Hematological MalignancyOncologyOverall Response RatesDifferent Induction TherapiesMalignant Blood Disorder +12

Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)

Michael Hundemer, Ulrike Klein, Dirk Hose, +8

Bone Marrow Transplantation

Hematological MalignancyMedicineHematologyImmunologyPathology +6

Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping

David C. Johnson, Sophie L. Corthals, Christine Ramos, +16

Blood

Recombinant human granulocyte and granulocyte–macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells

Stefan Hohaus, Hans Martin, Gerlinde Egerer, +6

Bone Marrow Transplantation

Cell TherapyGranulocyteMedicineStem Cell MobilizationRecombinant Human Granulocyte +10

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy (PN) in the APEX Trial.

Jesús F. San Miguel, Paul G. Richardson, Pieter Sonneveld, +16

Blood

Performance assessment and benchmarking of autologous peripheral blood stem cell collection with two different apheresis devices

Patrick Wuchter, Michael Hundemer, Anita Schmitt, +5

Transfusion Medicine